Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma

NCT00478062 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Lymphoma

Interventions

BIOLOGICAL: Hodgkin's antigens-GM-CSF-expressing cell vaccine
PROCEDURE: adjuvant therapy

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]